SUD Reprocessing Guidance Retains Premarket Exemptions For Now
FDA has not yet decided whether it will retain premarket exemptions for reprocessed Class I/II single-use devices (SUDs), according to the Aug 2 final guidance "Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals."
More from Archive
More from Medtech Insight
Despite Danaher’s confident outlook, the company acknowledged near-term profitability fluctuations, particularly in the second quarter. Matt McGrew, Danaher’s CFO, clarified during the company’s first-quarter earnings call on 22 April, that expected operating margin softness in the second quarter – forecast at 25.5% – was not related to tariffs, but to seasonal dynamics in its respiratory diagnostics business.
While the initial focus is medical devices and life sciences, Ketryx sees future opportunities in other high-regulation sectors including automotive, aerospace and defense, pharma manufacturing and nuclear systems.
Health and Human Services Secretary Robert F. Kennedy Jr. emphasized administrative cost reductions and defended budget decisions during a Senate hearing on HHS funding. Some senators, however, expressed concerns over the impacts spending cuts had on essential health programs.